V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196348 | 20125172 | 1.65 | 46.6 | Adjuvant (A) | 2016-11-22 | 2016-11-27 | Cetuximab 14 day | N | N | CAPECITABINE + CISPLATIN | 100631688 |
| 20196349 | 20125173 | 1.72 | 84.5 | Palliative (P) | 2016-08-12 | 2016-08-12 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101052484 |
| 20196352 | 20125174 | 1.82 | 71.8 | Palliative (P) | 2016-12-04 | 2017-03-20 | Cetuximab 14 day | N | N | CETUXIMAB | 101783813 |
| 20196355 | 20125175 | 1.59 | 65 | Palliative (P) | 2018-09-26 | 2018-09-26 | CETUXIMAB | N | Y | CAPECITABINE + CISPLATIN | 100838472 |
| 20196358 | 20125176 | 1.78 | 79 | Palliative (P) | 2020-02-07 | 2020-04-12 | CETUXIMAB | N | N | CETUXIMAB | 101806612 |
| 20196364 | 20125177 | 1.67 | 46.6 | Adjuvant (A) | 2019-07-06 | 2019-10-13 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100352984 |
| 20196366 | 20125178 | 1.8 | 69.1 | Neo-adjuvant (N) | 2018-11-26 | 2019-05-02 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101068736 |
| 20196370 | 20125179 | 1.59 | 82.25 | Palliative (P) | 2019-12-09 | 2020-01-03 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100677809 |
| 20196373 | 20125180 | 1.7 | 77.1 | Curative (C) | 2012-01-08 | 2016-08-27 | Trastuzumab Subcutaneous | N | null | TRASTUZUMAB | 100102800 |
| 20196374 | 20125181 | null | null | Neo-adjuvant (N) | 2018-08-27 | 2018-10-01 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101678471 |
| 20196376 | 20125182 | 1.62 | 62 | Adjuvant (A) | null | 2019-11-14 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101820753 |
| 20196378 | 20125183 | 1.72 | 54.35 | 03 | null | 2016-07-09 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100585661 |
| 20196384 | 20125184 | 1.8 | 85 | Neo-adjuvant (N) | 2016-11-18 | 2016-12-25 | Trastuzumab | N | N | TRASTUZUMAB | 101096880 |
| 20196386 | 20125185 | 1.5 | null | Curative (C) | 2017-08-28 | 2017-09-20 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100838669 |
| 20196388 | 20125186 | 1.75 | 47.8 | Neo-adjuvant (N) | 2017-06-16 | 2017-06-24 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100149281 |
| 20196389 | 20125187 | 1.77 | 77 | Palliative (P) | 2021-02-14 | 2021-02-14 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 100550833 |
| 20196402 | 20125188 | 1.73 | 0 | Neo-adjuvant (N) | 2019-08-09 | 2019-10-17 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100022340 |
| 20196406 | 20125189 | 1.7 | null | Curative (C) | 2017-03-30 | 2017-04-07 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100865955 |
| 20196412 | 20125190 | 1.55 | 81.85 | null | 2016-07-24 | 2016-07-31 | CETUXIMAB | 02 | null | CAPECITABINE + CISPLATIN | 100921389 |
| 20196417 | 20125191 | 1.66 | 55.5 | null | 2017-08-08 | 2017-08-20 | Trastuzumab | 02 | N | TRASTUZUMAB | 101299887 |
| 20196422 | 20125192 | 1.81 | 50 | Neo-adjuvant (N) | 2019-01-08 | 2019-02-12 | Trastuzumab | 02 | N | TRASTUZUMAB | 100135700 |
| 20196424 | 20125193 | 0 | 70.7 | Neo-adjuvant (N) | 2019-11-10 | 2019-11-10 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100854103 |
| 20196429 | 20125194 | 1.59 | 86 | null | 2016-10-16 | 2016-10-16 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100000349 |
| 20196430 | 20125195 | 1.56 | 72.7 | Neo-adjuvant (N) | 2017-07-01 | 2018-01-12 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100932751 |
| 20196433 | 20125196 | 1.81 | 80 | Neo-adjuvant (N) | 2019-05-01 | 2019-09-21 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100833860 |
| 20196436 | 20125197 | 1.89 | 71.8 | Neo-adjuvant (N) | 2017-02-04 | 2017-03-11 | CETUXIMAB | 02 | N | CETUXIMAB | 101012856 |
| 20196437 | 20125198 | 1.65 | 47 | Neo-adjuvant (N) | 2019-12-06 | 2019-12-13 | CETUXIMAB | 02 | N | CETUXIMAB | 100427990 |
| 20196438 | 20125199 | 1.72 | 65.05 | Curative (C) | 2016-06-11 | 2016-06-11 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101074379 |
| 20196442 | 20125200 | 1.76 | 39 | Curative (C) | 2018-05-20 | 2018-08-10 | Capecitabine + Cisplatin | 2 | N | CAPECITABINE + CISPLATIN | 101390982 |
| 20196445 | 20125201 | 1.77 | 52.5 | Neo-adjuvant (N) | 2018-01-18 | 2018-01-29 | Trastuzumab | 02 | N | TRASTUZUMAB | 100484410 |
| 20196449 | 20125202 | 1.75 | 67 | Adjuvant (A) | 2020-04-14 | 2020-04-20 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101685904 |
| 20196451 | 20125203 | 1.72 | 65 | Neo-adjuvant (N) | 2017-06-09 | 2017-07-01 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 101133338 |
| 20196456 | 20125204 | 1.9 | 55.4 | null | 2016-01-31 | 2016-02-09 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101533796 |
| 20196457 | 20125205 | 1.73 | 64.45 | null | 2016-12-24 | 2017-01-15 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 101693148 |
| 20196460 | 20125206 | 1.82 | 84.8 | Palliative (P) | 2018-06-15 | 2018-06-22 | CETUXIMAB | 02 | N | CETUXIMAB | 101222930 |
| 20196461 | 20125207 | 1.59 | null | Neo-adjuvant (N) | 2019-07-29 | 2019-08-19 | Trastuzumab | 02 | N | TRASTUZUMAB | 101725474 |
| 20196462 | 20125208 | 1.64 | 86.3 | Adjuvant (A) | 2015-12-16 | 2017-12-11 | CETUXIMAB | 02 | N | CETUXIMAB | 101337113 |
| 20196464 | 20125209 | 1.85 | 78.8 | Curative (C) | 2020-01-09 | 2020-01-16 | Cetuximab 14 day | 02 | Y | CETUXIMAB | 101852219 |
| 20196468 | 20125210 | 1.77 | 66.1 | Curative (C) | 2017-09-11 | 2017-09-18 | CETUXIMAB | N | N | TRASTUZUMAB | 101614579 |
| 20196470 | 20125211 | 1.58 | 71.2 | null | 2017-12-02 | 2017-12-30 | Cetuximab 14 day | 02 | null | TRASTUZUMAB | 100199702 |
| 20196471 | 20125212 | 1.7 | 81.4 | Neo-adjuvant (N) | null | 2016-06-06 | CETUXIMAB | 02 | N | CETUXIMAB | 100509215 |
| 20196473 | 20125213 | 1.72 | 82 | null | 2018-06-11 | 2018-08-06 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101272880 |
| 20196478 | 20125214 | 1.7 | 73.5 | null | 2015-08-03 | 2016-11-21 | Trastuzumab | 02 | null | TRASTUZUMAB | 101656441 |
| 20196481 | 20125215 | 1.81 | 77.3 | Palliative (P) | 2019-04-07 | 2019-04-15 | CETUXIMAB | 02 | null | TRASTUZUMAB | 100104437 |
| 20196482 | 20125216 | 1.7 | 98 | Curative (C) | 2019-06-13 | 2019-06-13 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101595021 |
| 20196487 | 20125217 | 1.82 | 71.8 | Palliative (P) | 2017-11-10 | 2017-11-16 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100255066 |
| 20196494 | 20125218 | 1.61 | 69 | null | 2017-10-15 | 2018-03-06 | Trastuzumab | 02 | null | TRASTUZUMAB | 100103938 |
| 20196495 | 20125219 | 1.81 | 81 | Curative (C) | 2019-11-14 | 2019-11-22 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN | 101228516 |
| 20196500 | 20125220 | 1.9 | 104 | 02 | 2016-09-08 | 2016-09-24 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100837250 |
| 20196502 | 20125221 | 1.75 | 56.3 | null | 2019-09-16 | 2019-09-24 | Trastuzumab | 02 | N | TRASTUZUMAB | 100696647 |